The ACME Laboratories Ltd. (DSE:ACMELAB)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
69.00
+0.90 (1.32%)
At close: May 29, 2025
3.76%
Market Cap 14.60B
Revenue (ttm) 34.75B
Net Income (ttm) 2.40B
Shares Out 211.60M
EPS (ttm) 11.36
PE Ratio 6.08
Forward PE n/a
Dividend 3.50 (5.07%)
Ex-Dividend Date Nov 21, 2024
Volume 76,486
Average Volume 66,787
Open 68.00
Previous Close 68.10
Day's Range 67.90 - 69.20
52-Week Range 62.60 - 94.50
Beta 0.10
RSI 38.03
Earnings Date Oct 22, 2025

About The ACME Laboratories

The ACME Laboratories Ltd., a pharmaceutical company, engages in the manufacture, market, and distribution of generic pharmaceutical formulation products in Bangladesh. The company offers pharmaceutical products in various therapeutic areas, such as allergic disorders, analgesic, antifribinolytic, anti-infective, antiviral, artificial sweeteners, cardiovascular, central nervous system (CNS), cough and cold, diabetes, eye care and preparations, gastroprokinetic, hepatobiliary, gastrointestinal, gynaecological, hand sanitizers, hormones and stero... [Read more]

Industry Pharmaceutical Preparations
Founded 1954
Employees 9,301
Stock Exchange Dhaka Stock Exchange
Ticker Symbol ACMELAB
Full Company Profile

Financial Performance

In 2024, The ACME Laboratories's revenue was 31.93 billion, an increase of 18.49% compared to the previous year's 26.95 billion. Earnings were 2.46 billion, an increase of 6.62%.

Financial Statements

News

There is no news available yet.